Dear Dr. Deyrup, I thoroughly enjoy your lectures. Just wanted to point out at 13.00 minutes - there is a minor error - the slide says immune complex mediated vasculitis (Goodpastures), I note that Goodpastures is a type 2 antibody mediated hypersensitivity. Keep up the great work! Jay
Very useful and I appreciate the VINDICATE mnemonic. I am looking forward to the future when we can “subtract” a target from our immune response. In the interim there are some promising complement inhibitors under development that should be helpful for many of these illnesses.
Dear Dr. Deyrup, I thoroughly enjoy your lectures. Just wanted to point out at 13.00 minutes - there is a minor error - the slide says immune complex mediated vasculitis (Goodpastures), I note that Goodpastures is a type 2 antibody mediated hypersensitivity. Keep up the great work! Jay
Very useful and I appreciate the VINDICATE mnemonic. I am looking forward to the future when we can “subtract” a target from our immune response. In the interim there are some promising complement inhibitors under development that should be helpful for many of these illnesses.
We actually add a "D" at Duke to address Disparities: VINDICATE(D). It gives us a chance to talk about access to care, exposure to toxins, etc.
Thanks for this. Very explicit and didactic 😊
Glad you enjoyed it!